CisplatinWorst hearing loss: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1912卷 / 1期

关键词：

D O I：

10.1007/s40278-022-17855-x

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：152 / 152

相关论文

共 50 条

[41] DecitabineFirst report of sudden hearing loss: case report
Reactions Weekly, 2014, 1507 (1) : 15 - 15
[42] FluvoxamineFirst report of hearing loss and tinnitus: case report
Reactions Weekly, 2009, 1260 (1) : 17 - 17
[43] ImatinibFirst report of irreversible hearing loss: case report
Reactions Weekly, 2008, 1204 (1) : 19 - 19
[44] TacrolimusFirst report of hearing loss and tinnitus: case report
Reactions Weekly, 1999, 762 (1) : 12 - 12
[45] Aminoglycosides/antibacterialsSensorineural hearing loss: case report
Reactions Weekly, 2015, 1544 (1) : 24 - 24
[46] Sodium valproateSensorineural hearing loss: case report
Reactions Weekly, 2014, 1524 (1) : 176 - 176
[47] CisplatinEarly sensorineural hearing loss: case report
Reactions Weekly, 2018, 1701 (1) : 88 - 88
[48] PembrolizumabAcute bilateral hearing loss: case report
Reactions Weekly, 2023, 1943 (1) : 570 - 570
[49] RegorafenibBilateral sensorineural hearing loss: case report
Reactions Weekly, 2019, 1784 (1) : 228 - 228
[50] StreptomycinProgressive sensorineural hearing loss: case report
Reactions Weekly, 2015, 1546 (1) : 186 - 186

← 1 2 3 4 5 →